Requires Adobe Acrobat ReaderRequires Adobe Acrobat Reader| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | ||
| Functioning Graft at Discharge | 1,922 | 1,982 | 2,008 | 1,977 | 1,899 | 1,867 | 1,958 | 2,040 | 2,070 | 2,039 | |
| With Immunosuppression Info | 1,912 | 1,976 | 1,983 | 1,966 | 1,885 | 1,853 | 1,936 | 1,999 | 2,059 | 2,026 | |
| Corticosteroids | Any in Category | 95.5% | 94.4% | 97.2% | 96.9% | 92.6% | 92.0% | 93.3% | 92.2% | 88.8% | 87.4% |
| Steroids | 95.5% | 94.4% | 97.2% | 96.9% | 92.6% | 92.0% | 93.3% | 92.2% | 88.8% | 87.4% | |
| Cyclosporine | Any in Category | 82.7% | 80.4% | 70.3% | 60.1% | 58.5% | 50.9% | 40.1% | 38.1% | 33.0% | 25.6% |
| Cyclosporin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.6% | 1.4% | 1.1% | 1.5% | |
| Sandimmmune | 11.2% | 8.1% | 4.3% | 2.8% | 3.4% | 2.9% | 2.1% | 1.5% | 1.2% | 0.6% | |
| Neoral | 71.4% | 70.6% | 57.7% | 44.5% | 40.6% | 33.3% | 25.5% | 26.8% | 23.5% | 17.6% | |
| Gengraf | 0.0% | 1.6% | 8.1% | 12.6% | 14.3% | 14.2% | 11.2% | 8.3% | 7.0% | 5.5% | |
| Eon | 0.0% | 0.0% | 0.2% | 0.2% | 0.1% | 0.4% | 0.7% | 0.2% | 0.2% | 0.3% | |
| Tacrolimus | Any in Category | 14.1% | 16.0% | 30.2% | 39.6% | 41.7% | 47.0% | 57.8% | 59.6% | 65.4% | 73.1% |
| Tacrolimus | 14.1% | 16.0% | 30.2% | 39.6% | 41.7% | 47.0% | 57.8% | 59.6% | 65.0% | 72.5% | |
| Everolimus | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.6% | |
| Antimetabolites | Any in Category | 82.6% | 88.2% | 91.0% | 84.4% | 89.2% | 94.9% | 94.3% | 91.4% | 91.9% | 92.5% |
| Mycophenolate Mofetil | 50.8% | 68.3% | 75.8% | 71.7% | 79.6% | 85.3% | 84.8% | 83.4% | 85.6% | 87.1% | |
| Mycophenolate Sodium | 0.0% | 0.0% | 0.0% | 0.4% | 0.2% | 0.1% | 1.4% | 3.4% | 3.4% | 2.7% | |
| Azathioprine | 31.5% | 19.5% | 14.9% | 12.2% | 9.3% | 9.6% | 8.1% | 4.7% | 2.9% | 2.8% | |
| Leflunomide | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Cytoxan | 0.3% | 0.4% | 0.3% | 0.2% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| mTOR Inhibitors | Any in Category | 1.4% | 2.9% | 4.3% | 10.0% | 8.4% | 5.3% | 4.2% | 6.2% | 4.5% | 3.4% |
| Sirolimus | 0.9% | 2.6% | 4.3% | 10.0% | 8.4% | 5.2% | 3.8% | 3.7% | 1.2% | 1.0% | |
| Everolimus | 0.5% | 0.4% | 0.0% | 0.1% | 0.0% | 0.2% | 0.4% | 2.6% | 3.3% | 2.4% | |
Requires Adobe Acrobat Reader